| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief People Officer | See Remarks | See Remark +2 more
1 company
Boyd Peter E. is a Chief People Officer at Aquestive Therapeutics, Inc.. Recent SEC Form 4 filings include 5 buys and 4 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | AQST Aquestive Therapeutics, Inc. | Chief People Officer | Sell | 29,814 | $4.17 | $124,413.82 | -8.1% | - | - | |
| Oct 15, 2025 | AQST Aquestive Therapeutics, Inc. | See Remarks | Sell | 10,000 | $7.00 | $70,000.00 | -3.6% | -53.4% | - | |
| Sep 26, 2025 | AQST Aquestive Therapeutics, Inc. | See Remarks | Sell | 10,000 | $6.30 | $63,000.00 | -3.5% | 0.0% | - | |
| Sep 5, 2025 | AQST Aquestive Therapeutics, Inc. | See Remarks | Sell | 15,000 | $5.30 | $79,500.00 | -4.9% | +18.8% | - | |
| Jun 14, 2022 | AQST Aquestive Therapeutics, Inc. | Svp-bus. Process &Info. Tech. | Buy | 5,000 | $0.81 | $4,050.00 | +9.2% | +72.5% | +164.7% | |
| Jun 8, 2022 | AQST Aquestive Therapeutics, Inc. | Svp-bus. Process &Info. Tech. | Buy | 2,293 | $0.96 | $2,201.28 | +4.4% | +38.6% | +138.4% | |
| Mar 16, 2020 | AQST Aquestive Therapeutics, Inc. | Svp-bus. Process &Info. Tech. | Buy | 2,000 | $1.50 | $3,000.00 | +4.0% | - | - | |
| Aug 12, 2019 | AQST Aquestive Therapeutics, Inc. | Svp-bus. Process &Info. Tech. | Buy | 600 | $3.81 | $2,286.00 | +1.2% | - | - | |
| Nov 21, 2018 | AQST Aquestive Therapeutics, Inc. | Svp-operations/ Value Delivery | Buy | 200 | $9.98 | $1,996.00 | +0.4% | - | - |